Eyewear/Optical

I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t…
Aequus Pharmaceuticals (AQS.V) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several…
Diagnos (ADK.V) announced today that it has signed a 7-year contract with Juarez Health & Medical Tourism Cluster (“Cluster”), headquartered in Ciudad Juarez located in the State of Chihuahua,…
Diagnos (ADK.V) announced today that it has signed a 3-year contract with Cielo Vista Eye Clinic in Mexico. According to the contract, Diagnos will supply its CARA platform to…
Diagnos (ADK.V) is definitely one of the companies with the coolest AI tech I have come across. I would use the word disruptive. And I like disruptive. I am…
Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract…
Aequus Pharmaceuticals (AQS.V) and reVision Therapeutics today announced a collaboration on the development of a therapy for Stargardt disease. The agreement will provide the Company with the option to…
Diagnos (ADK.V), a leader in early detection announced today that it has signed a pilot in Spain with three franchisees from Opticalia Group. “The campaign begins with the request…
Ocuphire Pharma (OCUP.Q), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for treatment of several eye disorders, announced today that its VEGA-1 Phase 2 clinical trial…